Clarivate Epidemiology's coverage of BRAF comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France, Germany,…
DRG Epidemiology’s coverage of epilepsy comprises epidemiological estimates of key patient populations in 45 countries. We report both the incidence and the prevalence of epilepsy for each…
DRG Epidemiology’s coverage of epilepsy comprises epidemiological estimates of key patient populations in 45 countries. We report both the incidence and the prevalence of epilepsy for each…
DRG Epidemiology’s coverage of epilepsy comprises epidemiological estimates of key patient populations in 45 countries. We report both the incidence and the prevalence of epilepsy for each…
DRG Epidemiology’s coverage of epilepsy comprises epidemiological estimates of key patient populations in 45 countries. We report both the incidence and the prevalence of epilepsy for each…
DRG Epidemiology’s coverage of epilepsy comprises epidemiological estimates of key patient populations in 45 countries. We report both the incidence and the prevalence of epilepsy for each…
DRG Epidemiology’s coverage of epilepsy comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain…
DRG’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key non-alcoholic steatohepatitis patient populations covering 171 countries…
The number of diagnosed prevalent cases of SCA in the countries under study will increase by 10% over the 20-year forecast period, from 29,000 to 32,000. Of the countries considered in this…
DRG Epidemiology's coverage of non-alcoholic fatty liver disease (NAFLD) comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the…
DRG Epidemiology's coverage of non-alcoholic steatohepatitis (NASH) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of…
DRG Epidemiology’s coverage of non-alcoholic fatty liver disease (NAFLD) comprises epidemiological estimates of key patient populations in 45 countries. We report the prevalence of NAFLD for each…
DRG Epidemiology's coverage of Irritable Bowel Syndrome comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of irritable bowel…
DRG Epidemiology's coverage of non-alcoholic fatty liver disease (NAFLD) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence…
Clarivate Epidemiology's coverage of IBS comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of IBS for each country, as well…